Mechanism of Biological Activity of Short Peptides: Cell Penetration and Epigenetic Regulation of Gene Expression
Review of earlier studies · 2013
- What was studied
- Review of earlier research
- Main finding
- Mechanistic review with a table of 15 short peptides on page 453. Tissue labels in the research map are the authors’ proposed targets, not established clinical indications.
Study data at a glance
- Participants or experimental model
- Review of earlier research
- Reported results
- Mechanistic review with a table of 15 short peptides on page 453. Tissue labels in the research map are the authors’ proposed targets, not established clinical indications.
Study limitations and source details
Study limitations
- Source-linked does not mean a completed risk-of-bias review.
- A review is not an independent clinical replication; proposed mechanisms do not establish efficacy or safety.
Source details
Author-hosted English PDF and its peptide table checked. Each cited experiment remains a separate appraisal task.
Sources checked
Citation
V. Kh. Khavinson, A. Yu. Solovyev, S. I. Tarnovskaya, N. S. Linkova. Mechanism of Biological Activity of Short Peptides: Cell Penetration and Epigenetic Regulation of Gene Expression Biology Bulletin Reviews 3(6):451–455
Study source ↗ · DOI 10.1134/S2079086413060042 · Bibliography entry · Link to this summary
Related compounds
Thymogen
A synthetic dipeptide, α-L-glutamyl-L-tryptophan (Glu–Trp, EW). Its alpha peptide bond and L-amino acids distinguish it from the gamma-linked immune peptides Bestim and Thymodepressin.
Vilon
A synthetic two-amino-acid peptide (Lys–Glu, or KE) studied in thymus, immune and tissue-repair research.
Normophthal
An oral ocular peptide preparation listed as a dipeptide in the Khavinson catalogue. Human studies examined its use alongside conventional care or after injected Retinalamin in age-related macular degeneration.
Cartalax
A synthetic tripeptide, Ala–Glu–Asp (AED, also called T-31), studied in cartilage, bone and joint research. Some related experiments used a cartilage extract containing AED.
Pinealon
A synthetic tripeptide, Glu–Asp–Arg (EDR). Researchers have examined its effects in neuronal aging models and measured functional outcomes in human performance studies.
Chonluten
A synthetic tripeptide, Glu–Asp–Gly (EDG), studied in bronchial and lung tissue models.
Vesugen
A synthetic three-amino-acid peptide (Lys–Glu–Asp, or KED) studied in vascular and cell-aging research.
Epitalon
A synthetic tetrapeptide, Ala–Glu–Asp–Gly (AEDG, also called Epithalon), developed from pineal-gland research. Human studies examined melatonin secretion, circadian markers and retinal function.
Prostamax
A synthetic tetrapeptide, Lys–Glu–Asp–Pro (KEDP), studied in prostate-cell research.
Livagen
A synthetic tetrapeptide, Lys–Glu–Asp–Ala (KEDA), studied in liver-cell research.
Cortagen
A synthetic tetrapeptide, Ala–Glu–Asp–Pro (AEDP), developed through research on Cortexin, a peptide mixture extracted from cerebral cortex.
Pancragen
A synthetic tetrapeptide, Lys–Glu–Asp–Trp (KEDW), studied in pancreatic tissue models and human glucose-metabolism research.
Cardiogen
A synthetic tetrapeptide, Ala–Glu–Asp–Arg (AEDR). Experiments in heart-tissue cultures examined cell proliferation and programmed cell death.
Testagen
A synthetic tetrapeptide, Lys–Glu–Asp–Gly (KEDG). Cell and DNA-binding studies examined molecular responses, and avian experiments examined endocrine function.
Bronchogen
A synthetic tetrapeptide, Ala–Glu–Asp–Leu (AEDL), studied in bronchial cells and respiratory disease.